Evidence map›Paper›PMID 32578969›Full record

ArticleESC heart failure2020

Atrial fibrillation ablation in heart failure patients: improved systolic function after cryoballoon pulmonary vein isolation.

Alexander Pott, Saskia Jäck, Christiane Schweizer, Michael Baumhardt, Tilman Stephan, Manuel Rattka, Karolina Weinmann, Carlo Bothner, Dominik Scharnbeck, Mirjam Keßler and 2 more

Open access · goldAbstract read
In one paragraph

Article in ESC heart failure, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Alexander PottMedicine II, Ulm University Medical Center, Ulm, Germany.
Saskia JäckMedicine II, Ulm University Medical Center, Ulm, Germany.
Christiane SchweizerMedicine II, Ulm University Medical Center, Ulm, Germany.
Michael BaumhardtMedicine II, Ulm University Medical Center, Ulm, Germany.
Tilman StephanMedicine II, Ulm University Medical Center, Ulm, Germany.
Manuel RattkaMedicine II, Ulm University Medical Center, Ulm, Germany.
Karolina WeinmannMedicine II, Ulm University Medical Center, Ulm, Germany.
Carlo BothnerMedicine II, Ulm University Medical Center, Ulm, Germany.
Dominik ScharnbeckMedicine II, Ulm University Medical Center, Ulm, Germany.
Mirjam KeßlerMedicine II, Ulm University Medical Center, Ulm, Germany.
Wolfgang RottbauerMedicine II, Ulm University Medical Center, Ulm, Germany.
Tillman DahmeMedicine II, Ulm University Medical Center, Ulm, Germany.
Universität Ulm · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsAtrial fibrillation (AF) and heart failure (HF) are the most common cardiac diseases and often coexist leading to increased mortality and morbidity compared with AF patients without HF. As shown previously, AF ablation using radio frequency (RF) in HF patients leads to a reduction of AF burden, an increase of left ventricular ejection fraction (LVEF) and consequently to reduced hospitalization and mortality. Previous AF ablation studies on HF patients have been liberal about additional targets beyond pulmonary vein isolation (PVI). Thus, the aim of this study was to assess systematically the impact of a straightforward PVI-only strategy on LVEF, NYHA functional class, and cardiovascular hospitalization rate in HF patients. METHODS AND

resultsOut of 414 consecutive patients undergoing PVI, only with the cryoballoon 113 patients with reduced LVEF [mean: 38.4 ± 10.8%, reduced ejection fraction (rEF) group] and 301 patients with normal LVEF (>55%) at baseline were identified [normal ejection fraction (nEF) group]. Remarkably, even though freedom from arrhythmia recurrence after 1 year was significantly lower in the rEF group (64.9%) compared with the nEF group (71.2%, P = 0.036), mean LVEF improved from 38.4 ± 10.8% to 52.5 ± 17.2% (P < 0.001) after cryoballoon ablation in the rEF group. Accordingly, HF-related symptoms as well as hospitalization rate declined significantly in the rEF group during follow-up compared with baseline.

conclusionsThe results of the present study suggest that catheter ablation restricted to a straightforward PVI-only strategy using the cryoballoon leads to improved left ventricular ejection fraction as well as improvement of NYHA functional class and increased freedom from cardiovascular rehospitalization.

Indexed as

Atrial FibrillationCatheter AblationCryosurgeryHeart FailurePulmonary VeinsHumansStroke VolumeTreatment OutcomeVentricular Function, LeftAtrial fibrillationCryoballoonHeart failureHospitalizationLeft ventricular systolic functionPulmonary vein isolation

Identifiers

PMID32578969
PMCPMC7524096
OpenAlexW3037933616

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.